Mental Health: Dual diagnosis - mental illness and substance use

Websites

• https://reasonsforusepackage.com/  Kroes S, & Myers K. (2018).  
• http://www.straightup.org.au/  The Straight Up documentaries explore the lived experience of people in recovery from mental health and substance issues and their carers.
• https://www.svhm.org.au/our-services/departments-and-services/n/nexus/resources Dual diagnosis resources by the NEXUS Team

Publications (last 5 years)

• Workforce perspectives of sustaining the utilisation of a harm reduction instrument in a mental health residential setting. Kroes S, McKim H, Petrakis M. Healthcare (Basel), 2024, 12(2)
• Integration of care in practice: Victorian examples of models of care, tools and activities that promote integrated treatment, care and support for people experiencing mental illness and substance use or addiction. Victorian Dual Diagnosis Initiative Leadership Group Working Group on Dual Diagnosis Integrated Treatment, Victorian Alcohol and Drug Association (VAADA). Includes contributions from Myers, K, Kroes, S. Melbourne; 2023
• Coproduction in evaluating a dual diagnosis tool with youth in a residential mental health service. Kroes S, Myers K, McLoughlan G, O'Connor S, Keily E, Petrakis M. Advances in Dual Diagnosis, 2023, 16(2):92-106 (abstract only)
• Adapting peer researcher facilitated strategies to recruit people receiving mental health services to a tobacco treatment trial. Baker AL, McCarter K, Brophy L, Castle D, Kelly PJ, Cocks N, McKinlay ML, ... Sweeney R. Frontiers in psychiatry Frontiers Research Foundation, 2022, 13:869169
• Reasons for Use Package: Outcomes From a Case Comparison Evaluation. Myers K, Kroes S, O’Connor S, & Petrakis M. Research on Social Work Practice, 2020, 30(7), 783-790.
• Yarra drug and health forum: A community approach to reducing harm associated with homelessness, mental illness and alcohol and drug use. Wearne P, Bryce J, Lim H, Mitchell S, Myers K, Wallis N, Willson A, & Burchell B. Parity, 2020, 33(4).
• Dual diagnosis assessment: A case study implementing the reasons for use package to engage a marginalised service user. Kroes S, Myers K, Officer S, O’Connor S, & Petrakis M. Cogent Medicine, 2019, 6(1), 1630097. 
• What should guide cross-sector collaborations between mental health and alcohol and other drug services? A scoping review. Minshall C, Stubbs J, Charleston R, Van-Dunem H, Wallace A, & Hynan C. Advances in Mental Health, 2019, 1-11
• Methamphetamine use in patients presenting to emergency departments and psychiatric inpatient facilities: what are the service implications? Unadkat A, Subasinghe S, Harvey RJ, & Castle DJ. Australasian Psychiatry, 2019, 27(1), 14-17.
• Psychosocial Factors Affecting Smoking Cessation Among People Living With Schizophrenia: A Lived Experience Lens. Cocks N, Brophy L, Segan C, Stratford A, Jones S, & Castle D. Frontiers in Psychiatry, 2019, 10(565).

Video from https://reasonsforusepackage.com/

• *Mental health nurses' attitudes towards consumers with co-existing mental health and drug and alcohol problems: A scoping review. Anandan, R, Cross, W, & Olasoji, M. Issues in Mental Health Nursing, 2021,  42(4), 346-357. 
• *Substance use and borderline personality disorder: Fostering hope in the face of complexity. Donald F, Arunogiri S, & Lubman DI. Australasian Psychiatry, 2019, 27(6), 569-572.
• Experiences of Professional Helping Relations by Persons with Co-occurring Mental Health and Substance Use Disorders. Brekke E, Lien L, & Biong S. International Journal of Mental Health & Addiction, 2018, 16(1), 53-65.
• *A sanctuary of safety: A study of how patients with dual diagnosis experience caring conversations. Priebe A, Wiklund Gustin L, & Fredriksson L. International Journal of Mental Health Nursing, 2018, 27(2), 856-865.

Client experience of services

• *Validation of a Comprehensive Patient Experience Survey for Addiction and Mental Health that was Co-designed with Service Users. Currie SR, Liu P, Adamyk-Simpson J, et al. Community Mental Health Journal, 2020, 56(4), 735-743.

Compulsory treatment

• Determinants of quality of life and treatment satisfaction during long-term involuntary in-patient treatment of dual-diagnosis patients. Van Kranenburg GD, Diekman WJ, Van den Brink RHS et al. Frontiers in psychiatry Frontiers Research Foundation, 2022, 13:801826
• Clinical effects and treatment outcomes of long-term compulsory in-patient treatment of treatment-resistant patients with severe mental illness and substance-use disorder. van Kranenburg GD, van den Brink RHS, Mulder WG, et al. BMC Psychiatry, 2019, 19(1), 270.
• The impact of substance use on treatment as a compulsory patient. Vine R, Tibble H, Pirkis J, et al. Australasian Psychiatry, 2019, 27(4), 378-382.

Coordination of services

• *Sustainment of integrated care in addiction treatment settings: Primary outcomes from a cluster-randomized controlled trial. Chokron Garneau H, Assefa MT, Jo B et al. Psychiatric Services, 2022, 73(3):280-286
• *Disconnect between psychiatric and addiction services: A review of patients' attendances at alcohol tobacco and other drug services after a psychiatric admission. Mohiuddin, SM, Mcdermott, B, & Dillon, J. Australasian Psychiatry, 2021,  29(1), 10-13. 
• Coordination of services for dual diagnosis clients in the interface between specialist and community care. Bjorkquist C, & Hansen GV. Journal of multidisciplinary healthcare, 2018, 11, 233-243.

Guidelines

• Scope, quality and inclusivity of international clinical guidelines on mental health and substance abuse in relation to dual diagnosis, social and community outcomes: A systematic review. Alsuhaibani, R, Smith, DC, Lowrie, R, et al. BMC Psychiatry, 2021,  21(1), 209. 

Inpatient services

• *Standardized drug and alcohol questions at admission to an acute adult mental health unit: clarifying the burden of dual diagnoses across a five-year period. Reilly J, McDermott B, & Dillon J. Australasian Psychiatry, 2019, 27(3), 270-274.
• *Care planning and nonpharmacological interventions in a metropolitan inpatient dual diagnosis service: A retrospective exploratory study. MacLeay E, Fry M, Roche MA, et al. International Journal of Mental Health Nursing, 2020, 03, 03.
• Factors Associated with Unplanned Early Discharges from a Dual Diagnosis Inpatient Detoxification Unit in Israel. Sofer MM, Kaptsan A, & Anson J. Journal of Dual Diagnosis, 2018, 14(3), 137-147.
• *Dual diagnosis and mechanical restraint - a register based study of 31,793 patients and 6562 episodes of mechanical restraint in the Capital region of Denmark from 2010-2014. Martensson S, Johansen KS, & Hjorthoj C. Nordic Journal of Psychiatry, 2019, 73(3), 169-177.

Recovery oriented practice

• Dilemmas in recovery-oriented practice to support people with co-occurring mental health and substance use disorders: a qualitative study of staff experiences in Norway. Brekke E, Lien L, Nysveen K, et al. International Journal of Mental Health Systems, 2018, 12, 30.

Technology

• The evaluation of the role of technology in the pathways to comorbidity care implementation project to improve management of comorbid substance use and mental disorders. Uribe Guajardo MG, Baillie A, Louie E et al. Journal of Multimorbidity and Comorbidity, 2022, 12:

Homeless

• *Living With Dual Diagnosis and Homelessness: Marginalized Within a Marginalized Group. Schutz C, Choi F, Jae Song M, et al. Journal of Dual Diagnosis, 2019, 15(2), 88-94.
• *Effects of comorbid substance use disorders on outcomes in a Housing First intervention for homeless people with mental illness. Urbanoski K, Veldhuizen S, Krausz M, et al. Addiction, 2018, 113(1), 137-145.

Prisoners

• Impact of dual diagnosis on healthcare and criminal justice costs after release from Queensland prisons: A prospective cohort study. Snow KJ, Petrie D, Young JT et al. Australian Journal of Primary Health, 2022, 28(3):264-270
• *Sharing power in criminal justice: The potential of co-production for offenders experiencing mental health and addictions in New Zealand. Thom K, & Burnside D. International Journal of Mental Health Nursing, 2018, 27(4), 1258-1265.

• Dual diagnosis competencies: A systematic review of staff training literature. Petrakis M, Robinson R, Myers K, Kroes S, & O'Connor S. Addictive Behaviors Reports, 2018, 7, 53-57.
• Before during after: a new harm reduction tool. Morrison B, Kroes S, Owens C, Fairclough J, Myers K, & Petrakis M. (2017). Book of Proceedings from the TheMHS Conference 2017: Embracing Change: Through Innovation and Lived Experience, Sydney, Australia.

Consumer viewpoint - a video from Polar Warriors

Consumer experience

• The experience of mood disorder and substance use: An integrative review. Crowe M, Inder M, Thwaites B. Journal of Psychiatric & Mental Health Nursing, 2023, 30(3):295-308
• Unraveling recovery: a qualitative study rooted in the lived experiences of persons with complex mental health needs. De Ruysscher C. Ghent University, 2019. 
• *'A place to be (me)': A qualitative study on an alternative approach to treatment for persons with dual diagnosis. De Ruysscher C, Vanheule S, & Vandevelde S. Drugs: Education, Prevention & Policy, 2019, 26(1), 50-59.
• *Reflections on a service user perspective in supporting persons with dual diagnosis: The case of Villa Voortman. Vandevelde S, Vander Laenen F, Ruysscher C, et al. International Journal of Mental Health and Addiction, 2018, 16(5), 1189-1192.
• *The Experiences of Older Adults with Dual Diagnosis in an Inner Melbourne Community Mental Health Service. Searby A, Maude P, & McGrath I. Issues in Mental Health Nursing, 2018, 39(5), 420-426.
• *The Concept of Recovery as Experienced by Persons with Dual Diagnosis: A Systematic Review of Qualitative Research From a First-Person Perspective. De Ruysscher C, Vandevelde S, Vanderplasschen W, et al. Journal of Dual Diagnosis, 2017, 13(4), 264-279.

Alcoholics Anonymous

• *AA attendance and abstinence for dually diagnosed patients: a meta-analytic review. Tonigan JS, Pearson MR, Magill M, et al. Addiction, 2018, 113(11), 1970-1981

Animal assisted therapy

• The efficacy of animal-assisted therapy in patients with dual diagnosis: Schizophrenia and addiction. Monfort M, Benito A, Haro G et al. International Journal of Environmental Research & Public Health [Electronic Resource], 2022, 19(11):30

Brief interventions

• The effect of brief interventions for alcohol among people with comorbid mental health conditions: A systematic review of randomized trials and narrative synthesis. Boniface S, Malet-Lambert I, Coleman R et al. Alcohol & Alcoholism, 2018, 53(3):282-293 

DBT and Mentalization

• A comparison of telehealth versus in-person group therapy: Results from a DBT-based dual diagnosis IOP. Bean CAL, Aurora P, Maddox CJ et al. Journal of Clinical Psychology, 2022, 78(11):2073-2086
• Does an adapted Dialectical Behaviour Therapy skills training programme result in positive outcomes for participants with a dual diagnosis? A mixed methods study. Flynn D, Joyce M, Spillane A, et al. Addiction Science & Clinical Practice, 2019, 14(1), 28.
• Early therapeutic process related to dropout in mentalization-based treatment with dual diagnosis patients. Philips B, Karlsson R, Nygren R, et al. Psychoanalytic Psychology, 2018, 35(2), 205-216.

Medication

• A feasibility study of patients with major depression and substance use disorders: Vortioxetine as maintenance treatment. Basurte-Villamor I, Vega P, Roncero C et al. Neuropsychiatric Disease and Treatment, 2022, 18:965-976
• Treatment with aripiprazole once-monthly injectable formulation is effective in improving symptoms and global functioning in schizophrenia with and without comorbid substance use - a post hoc analysis of the RELIAM study. Margolese HC, Boucher M, Therrien F et al. BMC Psychiatry, 2022, 22(1):773

Motivational interviewing

• *Motivational interviewing and dual diagnosis clients: Enhancing self-efficacy and treatment completion. Moore M, Flamez B, & Szirony G. Journal of Substance Use, 2018, 23(3), 247-253. 

Video from https://motivationalinterviewing.org/

Preventive interventions

• *Preventive interventions targeting cannabis use and related harms in people with psychosis: A systematic review. Coronado-Montoya, S, Morissette, F, Abdel-Baki, A, et al. Early intervention in psychiatry, 2021,  15(6), 1439-1453. 

Psychoeducation

• *Clinical outcomes from a 10-week follow-up psychoeducational program for dual diagnosis. Chilton J, Crone D, & Tyson P. Journal of Dual Diagnosis, 2018, 14(2), 102-110.
• *'The group was the only therapy which supported my needs, because it helped me feel normal and I was able to speak out with a voice': A qualitative study of an integrated group treatment for dual diagnosis service users within a community mental health setting. Chilton J, Crone DM, & Tyson PJ. International Journal of Mental Health Nursing, 2019, 29, 29.

Psychotherapy

• From feelings of imprisonment to group cohesion: A qualitative analysis of group analytic psychotherapy with dual diagnosed patients admitted to an acute inpatient psychiatric unit. Sanchez Morales L, Eiroa-Orosa FJ, Valls Llagostera C, et al. Psychotherapy Research, 2018, 28(3), 433-445.

Youth

• Scoping review of stepped care interventions for mental health and substance use service delivery to youth and young adults. Berger, M, Fernando, S, Churchill, A, et al. Early intervention in psychiatry, 2021,  21, 21. 

Staff training provider

• NEXUS Dual Diagnosis Consultation Service -  contact +61 3 9231 2083 or nexus@svha.org.au 

Publications

• Dual diagnosis competencies: A systematic review of staff training literature. Petrakis M, Robinson R, Myers K, et al. Addictive Behaviors Reports, 2018, 7, 53-57.
• *Improving the Knowledge, Attitudes, and Practices of Mental Health Professionals Regarding Dual Diagnosis Treatment - a Mixed Methods Study of an Intervention. Pinderup P. Issues in Mental Health Nursing, 2018, 39(4), 292-303.
• *Translating Evidence-Based Practice for Managing Comorbid Substance Use and Mental Illness Using a Multimodal Training Package. Louie E, Giannopoulos V, Baillie A, et al. Journal of Dual Diagnosis, 2018, 14(2), 111-119.
• *Brief Training on Medication-Assisted Treatment Improves Community Mental Health Clinicians' Confidence and Readiness to Address Substance Use Disorders. Iheanacho T, Bommersbach T, Fuehrlein B, et al. Community Mental Health Journal, 2020, 15, 15.

• Carers Can Ask - a resource for carers created by NEXUS Dual Diagnosis service
• *Surviving but not thriving: Burden of care and quality of life for caregivers of patients with schizophrenia spectrum disorders and comorbid substance use in South Africa. Yerriah J, Tomita A, Paruk S. Early intervention in psychiatry, 2022, 16(2):153-161

*Recovery, peer support and confrontation in services for people with mental illness and/or substance use disorder. Corrigan PW, Larson JE, Smelson D, et al. British Journal of Psychiatry, 2019, 214(3), 130-132.

Biomarkers

• *Eosinophils to lymphocytes ratio (ELR) as a potential inflammatory biomarker in patients with dual diagnosis of bipolar and alcohol use disorders: A retrospective cohort study. Dirani E, Bou Khalil R, Raad G et al. Journal of Dual Diagnosis, 2022, 18(3):144-152
• Neuroimaging Studies in Patients With Mental Disorder and Co-occurring Substance Use Disorder: Summary of Findings. Stoychev KR. Frontiers in psychiatry Frontiers Research Foundation, 2019, 10, 702.

Causes

• Chicken or egg: A dual diagnosis narrative. Cullen OJ, Norton MJ. Journal of Psychiatric & Mental Health Nursing, 2022, 29(4):507-511
• *A narrative literature review of the epidemiology, etiology, and treatment of co-occurring panic disorder and opioid use disorder. Clark, AE, Goodwin, SR, Marks, RM, et al. Journal of Dual Diagnosis, 2021,  17(4), 313-332. 
• *Schizophrenia is associated with increased risk of subsequent substance abuse diagnosis: A nation-wide population-based register study. Petersen SM, Toftdahl NG, Nordentoft M, et al. Addiction, 2019, 114(12), 2217-2226.

Characteristics

• *Redd-pac cohort description: Researching dual diagnosis-prognosis and characteristics. Martensson S, Johansen KS, Krarup J et al. Journal of Dual Diagnosis, 2022, 18(2):111-122
• *Personality traits in individuals with the dual diagnosis of psychosis and substance use disorders: A comprehensive review and meta-analysis. Oh, H, Jang, SK, Lee, HS, et al. Journal of Dual Diagnosis, 2021,  17(1), 34-51. 
• *Patient Characteristics Predicting Abstinence in Substance Use Disorder Patients With Comorbid Mental Disorders. van Hagen LJ, de Waal MM, Christ C, et al. Journal of Dual Diagnosis, 2019, 15(4), 312-323.

Other comorbidities

• *Impairments in executive functioning in patients with comorbid substance use and personality disorders: A systematic review. Moraleda-Barreno, E, Caceres Pachon, MDP, Lozano, OM, et al. Journal of Dual Diagnosis, 2021,  17(1), 64-79. 
• *Comorbidity of Physical Disorders Among Patients With Severe Mental Illness With and Without Substance Use Disorders: A Systematic Review and Meta-Analysis. Onyeka In MMBAP, Collier Hoegh M M, Naheim Eien Em CM, et al. Journal of Dual Diagnosis, 2019, 15(3), 192-206.

Prevalence

• *Comorbid substance use in psychosis: Someone else's problem? Lappin JM. Australian & New Zealand Journal of Psychiatry, 2022, 56(1):5-7
• Associations of common mental disorder with alcohol use in the adult general population: A systematic review and meta-analysis. Puddephatt, JA, Irizar, P, Jones, A, et al. Addiction, 2021,  02, 02. 
• *Comorbidity between mood and substance-related disorders: A systematic review and meta-analysis. Saha, S, Lim, CC, Degenhardt, L, et al. Australian & New Zealand Journal of Psychiatry, 2021, 48674211054740.